Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Pediatric Inflammatory Multisystem Syndrome (PIMS) - Potential role for cytokines such Is IL-6

L. Lacina, J. Brábek, Š. Fingerhutová, J. Zeman, K. Smetana

. 2021 ; 70 (2) : 153-159. [pub] 20210430

Language English Country Czech Republic

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc22000832

COVID-19 is a transmissible respiratory disease caused by coronavirus SARS-CoV-2, which is similar to SARS or MERS. Its increased severity was noted in aged patients usually over 65 years of age. Children and young people have an asymptomatic or mild course of the disease.Unfortunately, the number of children with problems after mild or asymptomatic COVID-19 recovery is increasing and their troubles resemble Kawasaki disease, although the laboratory findings seem to be different. This condition is called pediatric inflammatory multisystem syndrome (PIMS), and it is a new disease seen in children directly influenced by previous SARS-CoV-2 infection. The literature reports that PIMS typically follows 2-4 weeks after SARS-CoV-2 infection. The clinical symptoms of the affected children are extremely complex, ranging from gastrointestinal to cardiovascular problems with frequent skin and mucosal manifestations, and without intensive treatment they can be fatal. The exact causes of PIMS are recently unknown, however, it is explained as hyperactivation of immunity.In this minireview, we summarize data on the prominent role of the IL-6-IL-6R-STAT3 axis in PIMS aetiopathogenesis. Therapeutic manipulation of IL-6 or IL-6 receptor could be an approach to the treatment of children with severe PIMS.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc22000832
003      
CZ-PrNML
005      
20220202102629.0
007      
ta
008      
220106s2021 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934673 $2 doi
035    __
$a (PubMed)33992044
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Lacina, Lukáš, $d 1979- $7 xx0106429 $u Charles University, First Faculty of Medicine, Institute of Anatomy, Prague, Czech Republic $u Charles University, First Faculty of Medicine and General University Hospital in Prague, Department of Dermatovenerology, Prague, Czech Republic $u Charles University, First Faculty of Medicine, BIOCEV, Vestec, Czech Republic
245    10
$a Pediatric Inflammatory Multisystem Syndrome (PIMS) - Potential role for cytokines such Is IL-6 / $c L. Lacina, J. Brábek, Š. Fingerhutová, J. Zeman, K. Smetana
504    __
$a Literatura
520    9_
$a COVID-19 is a transmissible respiratory disease caused by coronavirus SARS-CoV-2, which is similar to SARS or MERS. Its increased severity was noted in aged patients usually over 65 years of age. Children and young people have an asymptomatic or mild course of the disease.Unfortunately, the number of children with problems after mild or asymptomatic COVID-19 recovery is increasing and their troubles resemble Kawasaki disease, although the laboratory findings seem to be different. This condition is called pediatric inflammatory multisystem syndrome (PIMS), and it is a new disease seen in children directly influenced by previous SARS-CoV-2 infection. The literature reports that PIMS typically follows 2-4 weeks after SARS-CoV-2 infection. The clinical symptoms of the affected children are extremely complex, ranging from gastrointestinal to cardiovascular problems with frequent skin and mucosal manifestations, and without intensive treatment they can be fatal. The exact causes of PIMS are recently unknown, however, it is explained as hyperactivation of immunity.In this minireview, we summarize data on the prominent role of the IL-6-IL-6R-STAT3 axis in PIMS aetiopathogenesis. Therapeutic manipulation of IL-6 or IL-6 receptor could be an approach to the treatment of children with severe PIMS.
650    _2
$a mladiství $7 D000293
650    _2
$a COVID-19 $x komplikace $x etiologie $x patofyziologie $7 D000086382
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    12
$a cytokiny $7 D016207
650    _2
$a lidé $7 D006801
650    12
$a interleukin-6 $7 D015850
650    _2
$a syndrom systémové zánětlivé reakce $x etiologie $x patofyziologie $7 D018746
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Brábek, Jan $7 xx0268678 $u Charles University, First Faculty of Medicine and General University Hospital in Prague, Department of Dermatovenerology, Prague, Czech Republic
700    1_
$a Fingerhutová, Šárka $7 xx0268704 $u Charles University, First Faculty of Medicine and General University Hospital in Prague, Department of Pediatrics and Inherited Metabolic Disorders, Prague, Czech Republic
700    1_
$a Zeman, Jiří, $d 1950- $7 skuk0001517 $u Charles University, First Faculty of Medicine and General University Hospital in Prague, Department of Pediatrics and Inherited Metabolic Disorders, Prague, Czech Republic
700    1_
$a Smetana, Karel, $d 1958- $7 jn20000710554 $u Charles University, First Faculty of Medicine, Institute of Anatomy, Prague, Czech Republic $u Charles University, First Faculty of Medicine, BIOCEV, Vestec, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 70, č. 2 (2021), s. 153-159
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33992044 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20220106 $b ABA008
991    __
$a 20220202102618 $b ABA008
999    __
$a ok $b bmc $g 1755663 $s 1151978
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 70 $c 2 $d 153-159 $e 20210430 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20220106
Back

Find record

Citation metrics

Archiving options